Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junko Murai

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Molecular Cancer Therapeutics|July 16, 2014
Biochemical assays for the discovery of TDP1 inhibitorsChristophe Marchand, Shar-yin N Huang, Thomas S Dexheimer, et al.
Plos One|November 18, 2017
ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repairMasataka Tsuda, Kosai Cho, Masato Ooka, et al.
Anticancer Research|February 27, 2026
SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell CarcinomaYohei Okuda, Junko Murai, Tsuyoshi Takashima, et al.
Molecular Cell|February 5, 2025
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosisAkane Ogawa, Keiichi Izumikawa, Sota Tate, et al.
Neuro-Oncology|October 23, 2022
Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Junko Murai, Masayasu Okada, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Molecular Cancer Therapeutics|July 16, 2014
Biochemical assays for the discovery of TDP1 inhibitorsChristophe Marchand, Shar-yin N Huang, Thomas S Dexheimer, et al.
Plos One|November 18, 2017
ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repairMasataka Tsuda, Kosai Cho, Masato Ooka, et al.
Anticancer Research|February 27, 2026
SLFN11 Drives GM-CSF-mediated M1 Macrophage Polarization and Enhances Immunotherapy Response in Renal Cell CarcinomaYohei Okuda, Junko Murai, Tsuyoshi Takashima, et al.
Molecular Cell|February 5, 2025
SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosisAkane Ogawa, Keiichi Izumikawa, Sota Tate, et al.
Neuro-Oncology|October 23, 2022
Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatinSatoshi Nakata, Junko Murai, Masayasu Okada, et al.
Pageof 8